The National Institute for Health Research (NIHR) has awarded Professor Reza Razavi and his team at Guy’s and St Thomas’ NHS Foundation Trust £1.4 million to support the development of new technologies for patients suffering from cardiovascular disease.

The funding will enable the creation of a Medtech and In vitro diagnostic Co-operative (MIC), run in partnership with King’s College London, which will develop new medical technologies for patients suffering from narrowed coronary arteries, heart rhythm problems, reduced heart pump function, narrow heart valves, and heart disease in children.

Professor Razavi, said: “We are delighted to receive this award from the NIHR which will allow us to establish a MIC at Guy’s and St Thomas’, and will allow us to continue the good work achieved by our NIHR Cardiovascular Healthcare Technology Co-operative.

“We will work in partnership with patients and patient groups, front-line staff, leading expert researchers, and the technology and device industry to develop healthcare solutions which will improve care for patients suffering from a wide range of cardiovascular conditions.”

In their awarding letter, the NIHR panel praised Professor Razavi’s application for being ‘comprehensive and ambitious’ and recognised the ‘strong track record’ that Guy’s and St Thomas’ and King’s College London have in developing medical devices, healthcare technologies and technology-dependent interventions. In light of the strength of the proposals the NIHR awarded an additional £94,000 to the Trust which will be made available to support more researcher projects.

The award was announced earlier this week to coincide with the publication of the government’s Life Science Industrial Strategy. Dr Louise Wood, Director of Science, Research and Evidence at the Department of Health said: “The £14.2 million funding received by the 11 NIHR Medtech and In vitro diagnostic Co-operatives across the country will make a real difference to patients’ lives and provide a focal point for the Medtech and in vitro diagnostic industries to develop new technologies and generate the evidence needed by the NHS to support the uptake of new tests”

The NIHR MICs will launch on 1 January 2018 and will replace the NIHR Healthcare Technology Co-operatives and NIHR Diagnostic Evidence Co-operatives. Funding will be provided over five years.

Guy’s and St Thomas’ hosts regional cardiology and cardiothoracic units with a diverse range of specialist cardiology and cardiac surgical services. Evelina London Children’s hospital, which is part of Guy’s and St Thomas’, has a large paediatric cardiology and cardiac surgery unit providing a comprehensive range of diagnostics and treatments.

King’s College London (KCL) is one of the world’s top 25 universities, and is ranked eight for medicine. Cardiovascular disease is the largest area of research with KCL’s School of Biomedical Engineering and Imaging Sciences (BMEIS). BMEIS is one of the world’s leading research groups in biomedical engineering with 420 staff and postgraduate research students and a focus on imaging, devises, robotics and computational modelling.